Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.
about
Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@en
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@nl
type
label
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@en
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@nl
prefLabel
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@en
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@nl
P2093
P2860
P1433
P1476
Factors influencing the use of ...... 1 year of the ACT-SOLO study.
@en
P2093
Isabelle Idier
Jacques Tebib
Jean-Francis Maillefert
Mathieu Coudert
Pascal Chazerain
René-Marc Flipo
P2860
P304
P356
10.1136/RMDOPEN-2016-000340
P577
2017-01-10T00:00:00Z